Paper Details

  1. Home
  2. Paper Details

Symptoms associated with tamoxifen treatment in postmenopausal women.

Author: CameronL, ConnellB L, LeventhalH, LoveR R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

Tamoxifen therapy in postmenopausal women with breast cancer was associated with significant perceived symptom 'cost', including vasomotor symptoms and gynecologic symptoms, potentially compromising long-term compliance.
Paper Details　
Original Abstract of the Article :
Adjuvant breast cancer therapy with tamoxifen is associated with greater disease-free survival and possibly overall survival. Long-term treatment, possibly of indefinite duration, is being evaluated. Compliance with long-term therapy will depend largely on the nature and severity of tamoxifen's side...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1888251

データ提供：米国国立医学図書館（NLM）

Tamoxifen Therapy: A Desert of Side Effects for Postmenopausal Women

Tamoxifen is a widely used medication for the treatment of breast cancer, offering significant benefits in reducing the risk of recurrence. However, like many medications, tamoxifen can come with a desert of side effects, particularly for postmenopausal women. This research investigates the symptoms associated with tamoxifen therapy in postmenopausal women with breast cancer in remission.

Navigating the Desert of Side Effects: A Balancing Act

The study reveals that tamoxifen therapy can lead to a range of side effects, including vasomotor symptoms (hot flashes, night sweats), gynecologic symptoms, and other major side effects. The authors highlight the importance of carefully monitoring for these side effects and of providing patients with appropriate support and management strategies to minimize their impact on quality of life. This research underscores the need for a balanced approach to tamoxifen therapy, weighing the benefits against the potential risks.

Finding the Oasis of Support: Empowering Patients to Make Informed Decisions

The study emphasizes the importance of open communication between patients and healthcare providers to ensure that women are fully informed about the potential side effects of tamoxifen therapy. The authors highlight the need to address patient concerns and to provide appropriate support and management strategies to minimize the impact of side effects. This research underscores the importance of patient-centered care and empowering women to make informed decisions about their treatment.

Dr. Camel's Conclusion

This research sheds light on the desert of side effects that can accompany tamoxifen therapy in postmenopausal women. The study highlights the importance of careful monitoring for these side effects and of providing patients with appropriate support and management strategies to minimize their impact on quality of life. This research underscores the need for a balanced approach to tamoxifen therapy, weighing the benefits against the potential risks, and for open communication between patients and healthcare providers to ensure that women are fully informed about their treatment options.

Date :
  1. Date Completed 1991-10-04
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1888251

DOI: Digital Object Identifier

1888251

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.